MedTrace Logo

The Role of CVP and EF in Patients With Cardio-renal Syndromes

NCT02792387 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2017-10-11

No results posted yet for this study

Summary

The aim of the study is to explore association between increased central venous pressure, Ejection Fraction and renal dysfunction (eGFR) in patients with Cardio-Renal Syndromes type 1 and 2. The pilot study was set to provide the expected correlation coefficient for a sample size determination of the subsequent study.

Conditions

Interventions

OTHER

CVP measurement

CVP measurements had been performed with an electronic pressure transducer in spontaneously breathing non-ventilated patients. Central vein access was established trough the subclavian or internal jugular veins. Mean CVP was recorded for each patient, measured in mmHg.

Sponsors & Collaborators

  • Tbilisi State University

    lead OTHER

Principal Investigators

  • George Lobzhanidze, MD · Tbilisi State University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-05-31
Completion
2017-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02792387 on ClinicalTrials.gov